Menu
Menu
IOL Chemicals and Pharmaceuticals has approved its first-ever five-for-one stock split, increasing liquidity and making its shares more accessible to investors. Learn how this move could impact shareholders and the company’s growth prospects in 2025.
In Q2 FY25, Bandhan Bank reported a remarkable 30% increase in net profit, reaching ₹937.4 crore. This blog explores the bank's strong financial performance, including rising net interest income and asset quality challenges. Discover key metrics and market reactions that underscore Bandhan Bank's position in the banking sector.
In Q2 FY25, Paytm achieved a net profit of Rs 928.3 crore, a significant turnaround from last year’s loss of Rs 290.5 crore. This remarkable result was primarily driven by a one-time gain from the sale of its entertainment ticketing business to Zomato. However, the company faced a 34.1% decline in operational revenue, raising questions about its long-term growth strategy. Dive into the details of this pivotal quarter and what it means for Paytm’s future.
Shilpa Medicare's shares surged following the company's announcement of receiving a Certificate of Suitability (CEP) from the EDQM for Desmopressin, a key active pharmaceutical ingredient. This approval not only highlights Shilpa's commitment to quality and innovation but also positions it for future growth in the pharmaceutical market. Explore the implications of this milestone and its potential impact on patients and investors.
In a successful move, SBI raised Rs 7,500 crore through its second tranche of Tier-II bonds at a coupon rate of 7.33%. This fully subscribed 15-year bond issue attracted significant interest from various institutional investors, reflecting strong market confidence in the bank. Discover the implications of this issuance and what’s next for SBI in the evolving debt market.
Dhanlaxmi Bank has reported a loss of Rs 8 crore for Q1 FY25, a sharp contrast to the previous year's profit. This blog delves into the underlying factors contributing to the bank's financial downturn, including increased provisions and operational hurdles. We also analyze what this means for the bank's future performance and offer insights for investors